HomeEKNCF • OTCMKTS
add
Eiken Chemical Co Ltd
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 10.91B | 6.67% |
Operating expense | 3.50B | 10.70% |
Net income | 807.00M | -15.32% |
Net profit margin | 7.40 | -20.60% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 28.65% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.87B | -55.59% |
Total assets | 63.57B | -2.49% |
Total liabilities | 18.20B | 21.94% |
Total equity | 45.37B | — |
Shares outstanding | 34.18M | — |
Price to book | — | — |
Return on assets | 4.23% | — |
Return on capital | 5.47% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 807.00M | -15.32% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment.
Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products.
The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, which is one of the most valuable tools in virtually all life science fields. Wikipedia
Founded
Feb 20, 1939
Website
Employees
757
